Innopharma Technology Launches Eyecon₂™ Particle Size Analyser at POWTECH

DUBLIN, Ireland Apr, 19th  2016 – Innopharma Technology, today launches Eyecon2™,  a non-product contact particle characteriser of powder based processes for the pharmaceutical, chemical and food industries at the POWTECH conference in Nuremberg, Germany.

The Eyecon2 particle size analyser is used as a real-time, in-line or at-line particle size and shape monitoring process analytical technology (PAT) instrument. This unique system can be utilised for both batch and continuous processes, giving the user a deeper understanding of particle size distribution changes during processing and to allow process endpoint control based on particle size distribution (PSD) evaluation during formulation development, scale-up, technology transfer and commercial manufacturing. 

Eyecon2 which is launched today at POWTECH will also be showcased during April at INTERPHEX April 26-28 New York, and MAKING PHARMACEUTICALS April 26-27, Birmingham, UK. 

“Eyecon2 embodies the insights we have gained from working with customers in delivering PAT solutions over the last number of years” said Dr Ian Jones, CEO and founder of Innopharma Labs Ltd. “Eyecon2 represents a significant enhancement of our capability in using direct imaging methodology for particle size measurement in applications such as fluid bed coating (Wurster), granulation (fluid bed, twin screw, roller compaction), milling and spheronising“.

Eyecon2 is the latest addition to the Innopharma Technology PAT family. The instrument is housed in a compact, lightweight stainless steel casing with quick release cabling for ease of movement and cleaning.  Eyecon2 features a new optimised optical pathway resulting in improved field of view and a wider particle size measurement range.

Eyecon2 also features the new Eyepass™ software which allows the user to quickly set up the instrument to measure a process. Eyepass software provides powerful report generation including D-Values, PSD, and captured images of particles.  Eyepass also provides controls for U.S. FDA 21 CFR part 11compliance and data integration capability via commonly used open platform communications (OPC). 

Sean Costello

Sean Costello leads the Technology Division, applying Industry 5.0 solutions to pharmaceutical, food and fine chemical industries. Prior to Innopharma, Sean was a founder of a Medical Device company and University spin-out SlidePath, which developed cloud-enabled AI-driven diagnostic decision support and automated workflow solutions for clinical histopathology, pharma drug discovery and drug safety. Sean holds a PhD in Pathology Imaging and Medical Informatics and a BSc in Biotechnology.

Darren McHugh

Darren McHugh is a Senior Product Manager at Innopharma Technology, with over 18 years of experience in the field of Manufacturing. He holds separate degrees in: Mechanical Engineering, Manufacturing Engineering, Pharmaceutical and Medical Device Manufacturing, and a Master’s in Product Management. He has worked with several companies in the manufacturing industry to help them implement smart manufacturing solutions into their processes. Darren is an expert in Industry 4.0 and 5.0 solutions, where he has used IIoT, image analysis and machine learning (ML) technologies to help companies capture the full potential of their digital transformation efforts and deliver a satisfactory return on investment.

Liam Ryan

Liam Ryan is a Sales & Marketing Manager at Innopharma Technology with over 12 years in Technology and Food & Beverage sectors. He has specialized in international business spending years working in China, US, Middle East & Europe with strong experience in the commercialization of new technologies in the marketplace.

Product and Process Mastery 

SmartXTM gives department teams better understanding of how critical process input parameters such as machine settings, operator training levels, or raw material options will affect product quality and outcomes.

Discover More 

 

Pharma Industry Awards 2021 Proud Sponsor